Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action
The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Abstract
To better understand the molecular mechanisms of depression and antidepressant action, we administered chronic social defeat stress followed by chronic imipramine (a tricyclic antidepressant) to mice and studied adaptations at the levels of gene expression and chromatin remodeling of five brain-derived neurotrophic factor (Bdnf) splice variant mRNAs (I-V) and their unique promoters in the hippocampus. Defeat stress induced lasting downregulation of Bdnf transcripts III and IV and robustly increased repressive histone methylation at their corresponding promoters. Chronic imipramine reversed this downregulation and increased histone acetylation at these promoters. This hyperacetylation by chronic imipramine was associated with a selective downregulation of histone deacetylase (Hdac) 5. Furthermore, viral-mediated HDAC5 overexpression in the hippocampus blocked imipramine's ability to reverse depression-like behavior. These experiments underscore an important role for histone remodeling in the pathophysiology and treatment of depression and highlight the therapeutic potential for histone methylation and deacetylation inhibitors in depression.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“chronic imipramine (a tricyclic antidepressant) administration to mice with chronic social defeat behavior was linked to a selective downregulation of HDAC5 in the hippocampus; viral-mediated HDAC5 overexpression blocked the antidepressant-like effect of imipramine.148”
From Epigenetic regulation in major depression and other stress-related disorders: molecular mechanisms, clinical relevance and therapeutic potential (2023) · cites this paper as [148]
In the citing paper
“In the depression mice model, features of abnormal energy metabolism have also been documented, including abnormal glucose metabolism, elevated lactate levels, mitochondrial dysfunction, and abnormal ATP levels [19–22].”
From APOE4 genotype exacerbates the depression-like behavior of mice during aging through ATP decline (2021) · cites this paper as [19]
In the citing paper
“Another attractive feature of this model is that social avoidance induced by 10 d of social defeat can be reversed by chronic, but not acute, antidepressant treatments17,27.”
From A standardized protocol for repeated social defeat stress in mice (2011) · cites this paper as [27]
In the citing paper
“One potential process involved in neuronal loss is decreased brain-derived neurotrophic factor (BDNF) via histone modifications to the promoter region associated with downregulation of BDNF transcripts73, 74.”
From Dysregulation of adult hippocampal neuroplasticity in major depression: Pathogenesis and therapeutic implications (2022) · cites this paper as [74]
In the citing paper
“In particular, antidepressant drugs rapidly activate TrkB signaling and gradually increase BDNF expression, and the behavioral effects of antidepressants are mediated by and dependent on BDNF signaling through TrkB at least in rodents.”
From Neuronal plasticity and neurotrophic factors in drug responses (2017) · cites this paper as [109]
8 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Jenuwein, T., & Allis, C. D. (2001) · Science · doi:10.1126/science.1063127 · Cited by 9,756 · cited 1×
“In general, histone acetylation (H3 and H4 acetylation) loosens DNA-histone interactions and allows the transcriptional machinery to bind and increase transcriptio”
BackgroundEpigenetic programming by maternal behavior
Weaver, I. C. G., Cervoni, N., Champagne, F. A., D'Alessio, A. C., Sharma, S., Seckl, J. R., Dymov, S., Szyf, M., & Meaney, M. J. (2004) · Nature Neuroscience · doi:10.1038/nn1276 · Cited by 6,177
Nestler, E. J., Barrot, M., DiLeone, R. J., Eisch, A. J., Gold, S. J., & Monteggia, L. M. (2002) · Neuron · doi:10.1016/s0896-6273(02)00653-0 · Cited by 3,217
Self-citationEssential role of BDNF in the mesolimbic dopamine pathway in social defeat stress
Berton, O., McClung, C. A., DiLeone, R. J., Krishnan, V., Renthal, W., Russo, S. J., Graham, D., Tsankova, N. M., Bolanos, C. A., Rios, M., et al. (2006) · Science · doi:10.1126/science.1120972 · Cited by 2,129
Self-citationNibuya, M., Morinobu, S., & Duman, R. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-11-07539.1995 · Cited by 2,109
Glucocorticoids and Hippocampal Atrophy in Neuropsychiatric Disorders
Sapolsky, R. M. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.10.925 · Cited by 2,016
High sensitivity mapping of methylated cytosines
Susan, J. C., Harrison, J., Paul, C. L., & Frommer, M. (1994) · Nucleic Acids Research · doi:10.1093/nar/22.15.2990 · Cited by 1,862
Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression
Shirayama, Y., Chen, A. C.-H., Nakagawa, S., Russell, D. S., & Duman, R. S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-08-03251.2002 · Cited by 1,654
Smith, M., Makino, S., Kvetnansky, R., & Post, R. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-03-01768.1995 · Cited by 1,440
Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila
Steffan, J. S., Bodai, L., Pallos, J., Poelman, M., McCampbell, A., Apostol, B. L., Kazantsev, A., Schmidt, E., Zhu, Y.-Z., Greenwald, M., et al. (2001) · Nature · doi:10.1038/35099568 · Cited by 1,228
Cited by
Items 801–900 of 1,012
Choi, M., Lee, S. H., Park, M. H., Kim, Y.-S., & Son, H. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.05.157 · Cited by 44
Histone Methylation in the Nervous System: Functions and Dysfunctions
Pattaroni, C., & Jacob, C. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8376-4 · Cited by 44
Antistress properties of antidepressant drugs and their clinical implications
Calabrese, F., Molteni, R., & Riva, M. A. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.05.007 · Cited by 44
Gavin, D. P., & Akbarian, S. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.12.008 · Cited by 44
Therapeutic Potential of Isoform Selective Hdac Inhibitors for the Treatment of Schizophrenia
Weïwer, M., Lewis, M. C., Wagner, F. F., & Holson, E. B. (2013) · Future Medicinal Chemistry · doi:10.4155/fmc.13.141 · Cited by 41
Genetic Variation in the Epigenetic Machinery and Mental Health
Murgatroyd, C., & Spengler, D. (2012) · Current Psychiatry Reports · doi:10.1007/s11920-012-0255-1 · Cited by 49
Repeated psychosocial stress at night, but not day, affects the central molecular clock
Bartlang, M. S., Savelyev, S. A., Johansson, A.-S., Reber, S. O., Helfrich-Förster, C., & Lundkvist, G. B. S. (2014) · Chronobiology International · doi:10.3109/07420528.2014.940085 · Cited by 41
Règue, M., Poilbout, C., Martin, V., Franc, B., Lanfumey, L., & Mongeau, R. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0431-8 · Cited by 39
Role of Salt-Induced Kinase 1 in Androgen Neuroprotection against Cerebral Ischemia
Cheng, J., Uchida, M., Zhang, W. H., Grafe, M. R., Herson, P. S., & Hurn, P. D. (2010) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2010.98 · Cited by 42
Real, E., Gratacòs, M., Soria, V., Escaramís, G., Alonso, P., Segalàs, C., Bayés, M., de Cid, R., Menchón, J. M., & Estivill, X. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.05.017 · Cited by 45
Mice Lacking Urea Transporter UT-B Display Depression-Like Behavior
Li, X., Ran, J., Zhou, H., Lei, T., Zhou, L., Han, J., & Yang, B. (2011) · Journal of Molecular Neuroscience · doi:10.1007/s12031-011-9594-3 · Cited by 47
What’s in a name? The three genealogies of the social in social epigenetics
Louvel, S. (2020) · Social Science Information · doi:10.1177/0539018419897001 · Cited by 42
Lolak, S., Suwannarat, P., & Lipsky, R. H. (2014) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-800977-2.00005-x · Cited by 46
Social defeat stress: Mechanisms underlying the increase in rewarding effects of drugs of abuse
Montagud‐Romero, S., Blanco-Gandía, M. C., Reguilón, M. D., Perez, C. F., Ballestín, R., Miñarro, J., & Rodríguez‐Arias, M. (2018) · European Journal of Neuroscience · doi:10.1111/ejn.14127 · Cited by 42
Oxytocin prevents the increase of cocaine-related responses produced by social defeat
Perez, C. F., Castro‐Zavala, A., Luján, M. Á., Filarowska, J., Ballestín, R., Miñarro, J., Valverde, O., & Rodríguez‐Arias, M. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.11.011 · Cited by 41
New insights on brain‐derived neurotrophic factor epigenetics: from depression to memory extinction
Poon, C. H., Heng, B. C., & Lim, L. W. (2021) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14458 · Cited by 40
Naghibi, S., Joneydi, M. S., Barzegari, A., Davoodabadi, A., Ebrahimi, A., Eghdami, E., Fahimpour, N., Ghorbani, M., Mohammadikia, E., Rostami, M., et al. (2021) · Physiology & Behavior · doi:10.1016/j.physbeh.2021.113595 · Cited by 43
Micale, V., Bartolomeo, M. D., Martino, S. D., Štark, T., Dell’Osso, B. M., Drago, F., & D’Addario, C. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108279 · Cited by 41
Targeting TrkB neurotrophin receptor to treat depression
Rantamäki, T., & Castrén, E. (2008) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.12.6.705 · Cited by 40
Cortisol and the Hypothalamic–Pituitary–Adrenal Axis in PTSD
Lehrner, A. L., Daskalakis, N. P., & Yehuda, R. (2016) · Wiley eBooks · doi:10.1002/9781118356142.ch11 · Cited by 57
Epigenetic Regulation of Axon Outgrowth and Regeneration in CNS Injury: The First Steps Forward
Lindner, R., Puttagunta, R., & Giovanni, S. D. (2013) · Neurotherapeutics · doi:10.1007/s13311-013-0203-8 · Cited by 43
Kubota, T. (2016) · Environmental Epigenetics · doi:10.1093/eep/dvw017 · Cited by 44
Cates, H. M., Heller, E. A., Lardner, C. K., Purushothaman, I., Peña, C. J., Walker, D. M., Cahill, M. E., Neve, R. L., Shen, L., Bagot, R. C., et al. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.11.027 · Cited by 40
Self-citationBrown, A., Fiori, L. M., & Turecki, G. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00229 · Cited by 43
You, D., Richardson, J. R., & Aleksunes, L. M. (2020) · Drug Metabolism and Disposition · doi:10.1124/dmd.119.089953 · Cited by 41
Erburu, M. M., Cajaleon, L., Guruceaga, E., Vénzala, E., Muñoz-Cobo, I., Beltrán, E., Puerta, E., & Tordera, R. M. (2015) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2015.06.001 · Cited by 43
Epigenetic regulation of genes in learning and memory
Roth, T. L., Roth, E. D., & Sweatt, J. D. (2010) · Essays in Biochemistry · doi:10.1042/bse0480263 · Cited by 42
Molecular assessment of depression from mRNAs in the peripheral leukocytes
Iga, J., Ueno, S., & Ohmori, T. (2008) · Annals of Medicine · doi:10.1080/07853890802082088 · Cited by 44
Chromatin in embryonic stem cell neuronal differentiation.
Meshorer, E. (2007) · PubMed · doi:10.14670/hh-22.311 · Cited by 49
WILLIAMS, E. S., Mazei‐Robison, M. S., & Robison, A. J. (2021) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a039198 · Cited by 44
Mishra, P. K., Kumar, A., Behar, K. L., & Patel, A. B. (2018) · Journal of Neurochemistry · doi:10.1111/jnc.14544 · Cited by 39
Self-citationRazzoli, M., Carboni, L., & Arban, R. (2009) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2009.04.018 · Cited by 45
The prevalence of epigenetic mechanisms in the regulation of cognitive functions and behaviour
Franklin, T. B., & Mansuy, I. M. (2010) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2010.04.007 · Cited by 46
RDoC and translational perspectives on the genetics of trauma‐related psychiatric disorders
Montalvo‐Ortiz, J. L., Gelernter, J. E., Hudziak, J. J., & Kaufman, J. (2015) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32395 · Cited by 44
Uwaya, A., Lee, H., Park, J., Lee, H., Muto, J., Nakajima, S., Ohta, S., & Mikami, T. (2016) · Behavioral and Brain Functions · doi:10.1186/s12993-016-0092-1 · Cited by 46
Implications of Epigenetic Mechanisms and their Targets in Cerebral Ischemia Models
Jhelum, P., Karisetty, B. C., Kumar, A., & Chakravarty, S. (2016) · Current Neuropharmacology · doi:10.2174/1570159x14666161213143907 · Cited by 40
Self-citationAhi1 regulates the nuclear translocation of glucocorticoid receptor to modulate stress response
Wang, B., Xin, N., Qian, X., Zhai, L., Miao, Z., Yong, Y., Li, S., Sun, M., Xu, X., & Li, X. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01305-x · Cited by 42
Defeating the fear: New insights into the neurobiology of stress susceptibility
Krishnan, V. (2014) · Experimental Neurology · doi:10.1016/j.expneurol.2014.05.012 · Cited by 40
Andersen, S. L., & Navalta, C. P. (2011) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.2011.02376.x · Cited by 38
Cooper, S. E., Kechner, M., Caraballo-Pérez, D., Kaska, S., Robison, A. J., & Mazei-Robison, M. S. (2017) · Scientific Reports · doi:10.1038/s41598-017-09106-3 · Cited by 38
The importance of epigenetics in diagnostics and treatment of major depressive disorder
Czarny, P., Białek, K., Ziółkowska, S., Strycharz, J., Barszczewska, G., & Sliwinski, T. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11030167 · Cited by 37
Rayan, N. A., Kumar, V., Aow, J., Rastegar, N., Lim, M. G. L., O’Toole, N., Aliwarga, E., Arcego, D. M., Yeo, G. H. T., Wong, J. Y., et al. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01725-1 · Cited by 42
Diverse Functions of Multiple Bdnf Transcripts Driven by Distinct Bdnf Promoters
You, H., & Lu, B. (2023) · Biomolecules · doi:10.3390/biom13040655 · Cited by 48
Lost in translation. New unexplored avenues for neuropsychopharmacology: epigenetics and microRNAs
Tardito, D., Mallei, A., & Popoli, M. (2013) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2013.749237 · Cited by 35
Molecular and genetic basis of depression
ROY, M., Tapadia, M. G., Joshi, S., & Koch, B. (2014) · Journal of Genetics · doi:10.1007/s12041-014-0449-x · Cited by 44
Barreto, R. A., Walker, F. R., Dunkley, P. R., Day, T. A., & Smith, D. W. (2012) · BMC Neuroscience · doi:10.1186/1471-2202-13-125 · Cited by 37
Alves, N. D., Patrício, P., Correia, J. S., Mateus‐Pinheiro, A., Machado-Santos, A. R., Loureiro‐Campos, E., Morais, M., Bessa, J. M., Sousa, N., & Pinto, L. (2017) · Brain Structure and Function · doi:10.1007/s00429-017-1490-3 · Cited by 43
Heinla, I., Åhlgren, J., Vasar, E., & Võikar, V. (2018) · Physiology & Behavior · doi:10.1016/j.physbeh.2018.01.024 · Cited by 40
Liang, X., Tang, J., Chao, F., Zhang, Y., Chen, L., Wang, F., Tan, C., Luo, Y., Xiao, Q., Zhang, L., et al. (2019) · Behavioural Brain Research · doi:10.1016/j.bbr.2019.112115 · Cited by 37
Alteba, S., Zer‐Aviv, T. M., Tenenhaus, A., David, G. B., Adelman, J. W., Hillard, C. J., Doron, R., & Akirav, I. (2020) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2020.08.005 · Cited by 40
Zhuo, R., Cheng, X., Luo, L., Yang, L., Zhao, Y., Zhou, Y., Lü, P., Jin, X., Cui, L., Liu, F., et al. (2022) · Pharmacology · doi:10.1159/000520990 · Cited by 38
Bonthuis, P. J., Patteson, J. K., & Rissman, E. F. (2011) · Endocrinology · doi:10.1210/en.2010-1001 · Cited by 37
The Role of the PACAP Signaling System in Depression
Pinhasov, A., Nesher, E., Gross, M., Turgeman, G., Kreinin, A., & Yadid, G. (2011) · Current Pharmaceutical Design · doi:10.2174/138161211795589328 · Cited by 40
Aberrant REST-mediated transcriptional regulation in major depressive disorder
Otsuki, K., Uchida, S., Wakabayashi, Y., Matsubara, T., Hobara, T., Funato, H., & Watanabe, Y. (2009) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2009.09.009 · Cited by 40
Monsey, M. S., Boyle, L. M., Zhang, M. L., Nguyen, C. P., Kronman, H. G., Ota, K. T., Duman, R. S., Taylor, J. R., & Schafe, G. E. (2014) · PLoS ONE · doi:10.1371/journal.pone.0091530 · Cited by 45
Molecular and Cellular Mechanisms of Antidepressant Action
Sharp, T. (2012) · Current Topics in Behavioral Neurosciences · doi:10.1007/7854_2012_216 · Cited by 36
Chronic Antidepressant Treatment in Normal Mice Induces Anxiety and Impairs Stress-coping Ability
Baek, I., Park, J. Y., & Han, P. (2015) · Experimental Neurobiology · doi:10.5607/en.2015.24.2.156 · Cited by 44
Pusalkar, M., Suri, D., Kelkar, A., Bhattacharya, A., Galande, S., & Vaidya, V. A. (2015) · Developmental Psychobiology · doi:10.1002/dev.21365 · Cited by 39
Social stress-induced hypothyroidism is attenuated by antidepressant treatment in rats
Olivares, E. L., Almeida, C. D. S., Pestana, F. M., Sonoda‐Côrtes, R., Araujo, I. G., Rodrigues, N. C., Mecawi, A. S., Côrtes, W. D. S., Marassi, M. P., Reis, L. C., et al. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.08.035 · Cited by 42
An updated overview of animal models in neuropsychiatry
Razafsha, M., Behforuzi, H., Harati, H., Wafai, R. A., Khaku, A. S., Mondello, S., Gold, M. S., & Kobeissy, F. H. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.02.045 · Cited by 44
Epigenetics in Suicide and Depression
Autry, A. E., & Monteggia, L. M. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.08.033 · Cited by 37
Herb, B. R., Shook, M. S., Fields, C. J., & Robinson, G. E. (2018) · BMC Genomics · doi:10.1186/s12864-018-4594-0 · Cited by 35
Myriad of implications of acetyl- l -carnitine deficits in depression
Post, R. M. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1811389115 · Cited by 37
Tomasi, J., Lisoway, A. J., Zai, C. C. H., Harripaul, R., Müller, D. J., Zai, G. C., McCabe, R. E., Richter, M. A., Kennedy, J. L., & Tiwari, A. K. (2019) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2019.09.002 · Cited by 45
The link among microbiota, epigenetics, and disease development
El-Sayed, A., Aleya, L., & Kamel, M. S. (2021) · Environmental Science and Pollution Research · doi:10.1007/s11356-021-13862-1 · Cited by 38
The Potential of KCNQ Potassium Channel Openers as Novel Antidepressants
Costi, S., Han, M., & Murrough, J. W. (2022) · CNS Drugs · doi:10.1007/s40263-021-00885-y · Cited by 38
Wijayatunge, R., Chen, L., Cha, Y. M., Zannas, A. S., Frank, C. L., & West, A. E. (2014) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2014.06.008 · Cited by 41
Hua, Y., Huang, X., Zhou, L., Zhou, Q., Hu, Y. F., Luo, C., Li, F. Y., & Zhu, D. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1200-1 · Cited by 40
Epigenetic Marking and Neuronal Plasticity
Duman, R. S., & Newton, S. S. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.04.037 · Cited by 39
Chakravarty, S., Jhelum, P., Bhat, U. A., Rajan, W. D., Maitra, S., Pathak, S. S., Patel, A. B., & Kumar, A. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.09.014 · Cited by 38
Self-citationThe epigenome and postnatal environmental influences in psychotic disorders
Pishva, E., Kenis, G., van den Hove, D., Lesch, K., Boks, M. P., van Os, J., & Rutten, B. P. F. (2014) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-014-0831-2 · Cited by 41
Kas, M. J., Krishnan, V., Gould, T. D., Collier, D. A., Olivier, B., Lesch, K., Domenici, E., Fuchs, E., Gross, C. T., & Ċastrén, E. (2011) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2010.12.001 · Cited by 38
Ferland, C. L., Harris, E. P., Lam, M., & Schrader, L. A. (2014) · Endocrinology · doi:10.1210/en.2013-1918 · Cited by 35
Understanding the epigenetics of neurodevelopmental disorders and DOHaD
Kubota, T., Miyake, K., Hariya, N., & Mochizuki, K. (2015) · Journal of Developmental Origins of Health and Disease · doi:10.1017/s2040174415000057 · Cited by 40
Lennartsson, A., Arner, E., Fagiolini, M., Saxena, A., Andersson, R., Takahashi, H., Noro, Y., Sng, J., Sandelin, A., Hensch, T. K., et al. (2015) · Epigenetics & Chromatin · doi:10.1186/s13072-015-0043-3 · Cited by 34
Mallei, A., Ieraci, A., & Popoli, M. (2018) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2018.1500029 · Cited by 38
Social Defeat Stress, Sex, and Addiction-Like Behaviors
Shimamoto, A. (2018) · International review of neurobiology · doi:10.1016/bs.irn.2018.07.009 · Cited by 38
Phenotypes, mechanisms and therapeutics: insights from bipolar disorder GWAS findings
Li, M., Li, T., Xiao, X., Chen, J., Hu, Z., & Fang, Y. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01523-9 · Cited by 41
N-Acetyl Cysteine Mitigates the Acute Effects of Cocaine-Induced Toxicity in Astroglia-Like Cells
Badisa, R. B., Kumar, S. S., MAZZIO, E. A., Haughbrook, R. D., Allen, J. R., Davidson, M. W., Fitch-Pye, C. A., & Goodman, C. B. (2015) · PLoS ONE · doi:10.1371/journal.pone.0114285 · Cited by 36
Oztan, O., Aydin, C., & Isgor, C. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.06.077 · Cited by 36
Morita, K., Gotohda, T., Arimochi, H., Lee, M., & Her, S. (2009) · Journal of Neuroscience Research · doi:10.1002/jnr.22072 · Cited by 34
Ambrus, L., Lindqvist, D., Träskman‐Bendz, L., & Westrin, Å. (2016) · Nordic Journal of Psychiatry · doi:10.1080/08039488.2016.1184310 · Cited by 36
Triple Reuptake Inhibitors (“Broad Spectrum” Antidepressants)
Skolnick, P., & Basile, A. S. (2007) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152707780363285 · Cited by 40
Arendt, D. H., Smith, J. P., Bastida, C. C., Prasad, M. S., Oliver, K. D., Eyster, K. M., Summers, T. R., Delville, Y., & Summers, C. H. (2012) · Physiology & Behavior · doi:10.1016/j.physbeh.2012.03.005 · Cited by 40
Crepaldi, L., & Riccio, A. (2009) · Epigenetics · doi:10.4161/epi.4.1.7604 · Cited by 39
Histone modifications of the Crhr1 gene in a rat model of depression following chronic stress
Wan, Q., Gao, K., Rong, H., Wu, M., Wang, H., Wang, X., Wang, G., & Liu, Z. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.05.031 · Cited by 36
Tzeng, W.-Y., Chuang, J., Lin, L.-C., Cherng, C. G., Lin, K., Chen, L.-H., Su, C., & Yu, L. (2012) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2012.07.002 · Cited by 34
Duclot, F., Jacquet, C., Gongora, C., & Maurice, T. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2010.03.077 · Cited by 40
Gene × environment interactions in the prediction of response to antidepressant treatment
Klengel, T., & Binder, E. B. (2013) · International Journal of Neuropsychopharmacology · doi:10.1017/s1461145712001459 · Cited by 34
Otabi, H., Goto, T., Okayama, T., Kohari, D., & Toyoda, A. (2016) · Behavioural Processes · doi:10.1016/j.beproc.2016.12.003 · Cited by 38
Shu, Y., & Xu, T. (2017) · Neural Plasticity · doi:10.1155/2017/6207873 · Cited by 39
Moving pharmacoepigenetics tools for depression toward clinical use
Hack, L. M., Fries, G. R., Eyre, H. A., Bousman, C. A., Singh, A. B., Quevedo, J., John, V. P., Baune, B. T., & Dunlop, B. W. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2019.02.009 · Cited by 33
Jha, S., Dong, B. E., Xue, Y., Delotterie, D. F., Vail, M. G., & Sakata, K. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.160 · Cited by 33
“It is also possible that loss of BDNF in conditional knockouts is insuf fi cient to cause depression-like behavior, but is prone to do so when BDNF levels are further reduced by inactive promoter IV under stress, 20,21 and females may be more susceptible to stress.”
The impact of antidepressants on human neurodevelopment: Brain organoids as experimental tools
Marinho, L. S. R., Chiarantin, G. M. D., Ikebara, J. M., Cardoso, D. S., de Lima-Vasconcellos, T. H., Higa, G. S. V., Ferraz, M. S. A., Pasquale, R. D., Takada, S. H., Papes, F., et al. (2022) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2022.09.007 · Cited by 36
Angelucci, F., Croce, N., Spalletta, G., Dinallo, V., Gravina, P., Bossù, P., Federici, G., Caltagirone, C., & Bernardini, S. (2011) · Pharmacology · doi:10.1159/000322528 · Cited by 33
Melas, P. A., Lennartsson, A., Vakifahmetoglu-Norberg, H., Wei, Y. B., Åberg, E., Werme, M. J. H., Rogdaki, M., Mannervik, M., Wegener, G., Brené, S., et al. (2013) · Translational Psychiatry · doi:10.1038/tp.2013.31 · Cited by 36
Presynaptic Plasticity as a Hallmark of Rat Stress Susceptibility and Antidepressant Response
Nieto-Gonzalez, J. L., Holm, M. M., Vardya, I., Christensen, T., Wiborg, O., & Jensen, K. (2015) · PLOS ONE · doi:10.1371/journal.pone.0119993 · Cited by 35
Personalized Medicine and Mood Disorders
Alhajji, L., & Nemeroff, C. B. (2015) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2015.05.003 · Cited by 39
Yu, X., Dong, R., Wang, H., Lin, J., An, Y., Du, Y., Tang, S., Hu, M. Y., Long, Y., Sun, H., et al. (2015) · Psychopharmacology · doi:10.1007/s00213-015-4136-2 · Cited by 34
Xin, D. L., Hadrévi, J., Elliott, M. E., Amin, M., Harris, M. Y., Barr-Gillespie, A. E., & Barbe, M. F. (2017) · BMC Neuroscience · doi:10.1186/s12868-017-0354-3 · Cited by 34
Metadata
- Authors
- Tsankova, N. M., Berton, O., Renthal, W., Kumar, A., Neve, R. L., & Nestler, E. J.
- Affiliations
- The University of Texas Southwestern Medical Center (US)
- Harvard University (US)
- Corresponding author
- Nestler, Eric J
- Venue
- Nature Neuroscience
- Published
- 2006-02-26
- Volume
- 9
- Issue
- 4
- Pages
- 519-525
- ISSN
- 1097-6256 (ISSN-L)
- 1546-1726
- OpenAlex
- W2130685024
- Cited by
- 1,780
- References
- 50
- Citations by year
- 2026: 34 · 2025: 32 · 2024: 52 · 2023: 37 · 2022: 53 · 2021: 73 · 2020: 68 · 2019: 96 · 2018: 81 · 2017: 102 · 2016: 118 · 2015: 106 · 2014: 134 · 2013: 117 · 2012: 146
- FWCI
- 55.39
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Nature Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Institute of Mental Health
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Keywords
- depression, antidepressant action, chronic social defeat stress, imipramine, hippocampus, chromatin remodeling, histone methylation, histone acetylation, HDAC5, depression-like behavior, histone deacetylase inhibitors
- MeSH terms
- Acetylation, Animals, Antidepressive Agents, Behavior, Animal, Chromatin, Depression, Disease Models, Animal, Hippocampus, Histones, Imipramine, Male, Methylation, Mice, Inbred C57BL, Stress, Psychological, Brain-Derived Neurotrophic Factor, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.